By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Retrophin, Inc. 

777 Third Avenue
22nd Floor
New York  New York  10017  U.S.A.
Phone: 646-564–3680 Fax:



Company News
Retrophin, Inc. (RTRX) Announces Changes To Board Of Directors And Management Team 9/17/2014 11:29:46 AM
Retrophin, Inc. (RTRX), Gilead Sciences, Inc. (GILD), And Our Healthcare Values 9/15/2014 6:47:12 AM
Retrophin, Inc. (RTRX) Reports Second Quarter 2014 Financial Results 8/12/2014 8:42:17 AM
Retrophin, Inc. (RTRX) To Report Second Quarter 2014 Financial Results 8/5/2014 10:04:41 AM
Clinuvel Snags A $95 Million Takeover Bid From New York-Based Retrophin, Inc. (RTRX) 7/28/2014 6:04:02 AM
Retrophin, Inc. (RTRX) Snags $91 Million 7/1/2014 4:13:01 PM
Retrophin, Inc. (RTRX) Slumps As Patient On Key Drug Shows High Liver Enzyme Levels 6/27/2014 10:09:35 AM
Retrophin, Inc. (RTRX) Enters Into U.S. License Agreement For Thiola® (Tiopronin) 5/30/2014 8:44:51 AM
Retrophin, Inc. (RTRX) Signs A $80 Million Term Loan And Convertible Note Issuing 5/30/2014 6:29:53 AM
Retrophin, Inc. (RTRX) Names Alvin Shih, M.D. Executive Vice President Of Research And Development 5/29/2014 8:04:37 AM